PMDS — PMD Device Solutions AB Share News
0.000.00%
- SEK13.76m
- SEK40.59m
- SEK28.62m
Brief: PMD Device Solutions Q3 EBITDA Loss Widens To SEK 8.9 Mln
Brief: Pmd Device Solutions Completes Sale Of Coala Life Monitor
Brief: PMDS’ Largest Shareholder Requests EGM To Appoint New Non-Executive Directors
Brief: PMDS Says RespiraSense Technology Demonstrates Capability In Predicting 7-Day Mortality
Brief: PMDS Secures New Contract In Western U.S.
Brief: PMD Device Solutions Secures Sales Contract In U.S.
Brief: PMDS Q2 EBITDA Loss Widens To SEK 8 Mln
Brief: PDMS Carries Out Rights Issue Of About SEK 27.5 Mln
Brief: PMDS To Carry Out Rights Issue Of SEK 27.5 Million
Brief: Pmd Device Solutions Q1 EBITDA Loss Narrows To SEK 1.6 Mln
Brief: PMD Device Solutions Signs LOI For Coala-Life Technology
Brief: PMD Device Solutions Intends To Buy Key Assets In Coala-Life
Brief: Rett Syndrome Research Trust Selects PMD Solutions' Respirasense
Brief: Pmd Device Solutions Starts Preparation For German Hospital Pilot
Brief: Pmd Device Solutions Q4 Net Sales Up At Ksek 10,082
Brief: Promore Pharma Says PMD Resolved On Private Placement Of About SEK 26.5 Mln
Brief: Promore Pharma To Carry Out Reverse Acquisition Of PMD Device Solutions
Brief: Promore Pharma Q3 Net Loss at SEK -3.9 Million
Brief: Promore Pharma Starts Voluntary Liquidation